AYTU
Price
$2.21
Change
+$0.02 (+0.91%)
Updated
Aug 15 closing price
Capitalization
19.84M
PBH
Price
$64.99
Change
+$0.39 (+0.60%)
Updated
Aug 15 closing price
Capitalization
3.2B
73 days until earnings call
Interact to see
Advertisement

AYTU vs PBH

Header iconAYTU vs PBH Comparison
Open Charts AYTU vs PBHBanner chart's image
Aytu BioPharma
Price$2.21
Change+$0.02 (+0.91%)
Volume$65.16K
Capitalization19.84M
Prestige Consumer Healthcare
Price$64.99
Change+$0.39 (+0.60%)
Volume$698.76K
Capitalization3.2B
AYTU vs PBH Comparison Chart in %
Loading...
AYTU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PBH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AYTU vs. PBH commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AYTU is a Hold and PBH is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 18, 2025
Stock price -- (AYTU: $2.21 vs. PBH: $64.99)
Brand notoriety: AYTU and PBH are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AYTU: 38% vs. PBH: 150%
Market capitalization -- AYTU: $19.84M vs. PBH: $3.2B
AYTU [@Pharmaceuticals: Generic] is valued at $19.84M. PBH’s [@Pharmaceuticals: Generic] market capitalization is $3.2B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.3B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AYTU’s FA Score shows that 0 FA rating(s) are green whilePBH’s FA Score has 0 green FA rating(s).

  • AYTU’s FA Score: 0 green, 5 red.
  • PBH’s FA Score: 0 green, 5 red.
According to our system of comparison, AYTU is a better buy in the long-term than PBH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AYTU’s TA Score shows that 4 TA indicator(s) are bullish while PBH’s TA Score has 4 bullish TA indicator(s).

  • AYTU’s TA Score: 4 bullish, 5 bearish.
  • PBH’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, PBH is a better buy in the short-term than AYTU.

Price Growth

AYTU (@Pharmaceuticals: Generic) experienced а -6.75% price change this week, while PBH (@Pharmaceuticals: Generic) price change was -0.90% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +6.26%. For the same industry, the average monthly price growth was +68.76%, and the average quarterly price growth was +80.82%.

Reported Earning Dates

PBH is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+6.26% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PBH($3.2B) has a higher market cap than AYTU($19.8M). AYTU YTD gains are higher at: 30.000 vs. PBH (-16.776). PBH has higher annual earnings (EBITDA): 362M vs. AYTU (10.6M). PBH has more cash in the bank: 97.9M vs. AYTU (18.2M). AYTU has less debt than PBH: AYTU (21.4M) vs PBH (1.04B). PBH has higher revenues than AYTU: PBH (1.14B) vs AYTU (81.7M).
AYTUPBHAYTU / PBH
Capitalization19.8M3.2B1%
EBITDA10.6M362M3%
Gain YTD30.000-16.776-179%
P/E RatioN/A15.26-
Revenue81.7M1.14B7%
Total Cash18.2M97.9M19%
Total Debt21.4M1.04B2%
FUNDAMENTALS RATINGS
AYTU vs PBH: Fundamental Ratings
AYTU
PBH
OUTLOOK RATING
1..100
7950
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
82
Overvalued
PROFIT vs RISK RATING
1..100
10043
SMR RATING
1..100
8562
PRICE GROWTH RATING
1..100
4986
P/E GROWTH RATING
1..100
6863
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AYTU's Valuation (42) in the Other Consumer Services industry is somewhat better than the same rating for PBH (82) in the Pharmaceuticals Other industry. This means that AYTU’s stock grew somewhat faster than PBH’s over the last 12 months.

PBH's Profit vs Risk Rating (43) in the Pharmaceuticals Other industry is somewhat better than the same rating for AYTU (100) in the Other Consumer Services industry. This means that PBH’s stock grew somewhat faster than AYTU’s over the last 12 months.

PBH's SMR Rating (62) in the Pharmaceuticals Other industry is in the same range as AYTU (85) in the Other Consumer Services industry. This means that PBH’s stock grew similarly to AYTU’s over the last 12 months.

AYTU's Price Growth Rating (49) in the Other Consumer Services industry is somewhat better than the same rating for PBH (86) in the Pharmaceuticals Other industry. This means that AYTU’s stock grew somewhat faster than PBH’s over the last 12 months.

PBH's P/E Growth Rating (63) in the Pharmaceuticals Other industry is in the same range as AYTU (68) in the Other Consumer Services industry. This means that PBH’s stock grew similarly to AYTU’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AYTUPBH
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
66%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
66%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
56%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
63%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
54%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
44%
Advances
ODDS (%)
Bullish Trend 6 days ago
75%
Bullish Trend 6 days ago
57%
Declines
ODDS (%)
Bearish Trend 12 days ago
89%
Bearish Trend 8 days ago
52%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
68%
Aroon
ODDS (%)
Bullish Trend 4 days ago
82%
Bearish Trend 4 days ago
36%
View a ticker or compare two or three
Interact to see
Advertisement
AYTU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PBH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IRSYX15.310.07
+0.46%
Macquarie Real Estate Securities Y
FBFZX12.70N/A
N/A
Franklin Managed Income Adv
PIBAX18.71-0.03
-0.16%
PGIM Balanced A
PRUIX169.83-0.45
-0.26%
T. Rowe Price Equity Index 500 I
HNMVX27.55-0.17
-0.61%
Harbor Mid Cap Value Retirement

AYTU and

Correlation & Price change

A.I.dvisor indicates that over the last year, AYTU has been loosely correlated with IXHL. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if AYTU jumps, then IXHL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AYTU
1D Price
Change %
AYTU100%
-3.49%
IXHL - AYTU
41%
Loosely correlated
-3.77%
PBH - AYTU
21%
Poorly correlated
+0.60%
ETON - AYTU
20%
Poorly correlated
+2.04%
CPHI - AYTU
20%
Poorly correlated
-2.05%
OGI - AYTU
20%
Poorly correlated
-8.33%
More

PBH and

Correlation & Price change

A.I.dvisor indicates that over the last year, PBH has been loosely correlated with PAHC. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if PBH jumps, then PAHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PBH
1D Price
Change %
PBH100%
+0.60%
PAHC - PBH
40%
Loosely correlated
+0.33%
PRGO - PBH
31%
Poorly correlated
-1.43%
AMRX - PBH
28%
Poorly correlated
+0.64%
AMPH - PBH
27%
Poorly correlated
-1.26%
APNHF - PBH
26%
Poorly correlated
N/A
More